Sebba A[au] - Search Results

Year	Number of Results
1987	1
1999	1
2002	1
2004	1
2005	1
2006	2
2007	1
2008	7
2009	5
2010	1
2011	1
2012	1
2013	3
2015	2
2016	2
2017	2
2020	2
2021	2
2022	0

1

The Jak/STAT pathway: A focus on pain in rheumatoid arthritis.

Simon LS, Taylor PC, Choy EH, Sebba A, Quebe A, Knopp KL, Porreca F. Simon LS, et al. Among authors: sebba a. Semin Arthritis Rheum. 2021 Feb;51(1):278-284. doi: 10.1016/j.semarthrit.2020.10.008. Epub 2020 Dec 18. Semin Arthritis Rheum. 2021. PMID: 33412435 Free article. Review.

2

Tocilizumab: the first interleukin-6-receptor inhibitor.

Sebba A. Sebba A. Am J Health Syst Pharm. 2008 Aug 1;65(15):1413-8. doi: 10.2146/ajhp070449. Am J Health Syst Pharm. 2008. PMID: 18653811 Review.

3

Efficacy and Safety of Ixekizumab with or Without Methotrexate in Biologic-Naïve Patients with Psoriatic Arthritis: 52-Week Results from SPIRIT-H2H Study.

Smolen JS, Sebba A, Ruderman EM, Schulze-Koops H, Sapin C, Gellett AM, Sprabery AT, Li L, de la Torre I, Gallo G, Liu-Leage S, Pillai S, Reis P, Nash P. Smolen JS, et al. Among authors: sebba a. Rheumatol Ther. 2020 Dec;7(4):1021-1035. doi: 10.1007/s40744-020-00250-3. Epub 2020 Nov 16. Rheumatol Ther. 2020. PMID: 33200394 Free PMC article.

4

Pain: A Review of Interleukin-6 and Its Roles in the Pain of Rheumatoid Arthritis.

Sebba A. Sebba A. Open Access Rheumatol. 2021 Mar 5;13:31-43. doi: 10.2147/OARRR.S291388. eCollection 2021. Open Access Rheumatol. 2021. PMID: 33707975 Free PMC article. Review.

5

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study.

Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T, Genovese MC. Jones G, et al. Among authors: sebba a. Ann Rheum Dis. 2010 Jan;69(1):88-96. doi: 10.1136/ard.2008.105197. Ann Rheum Dis. 2010. PMID: 19297346 Free PMC article. Clinical Trial.

6

Significance of a decline in bone mineral density while receiving oral bisphosphonate treatment.

Sebba AI. Sebba AI. Clin Ther. 2008 Mar;30(3):443-52. doi: 10.1016/j.clinthera.2008.03.008. Clin Ther. 2008. PMID: 18405784 Review.

7

Osteoporosis: how long should we treat?

Sebba A. Sebba A. Curr Opin Endocrinol Diabetes Obes. 2008 Dec;15(6):502-7. doi: 10.1097/MED.0b013e328317ca83. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18971678 Review.

8

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis.

Emery P, Sebba A, Huizinga TW. Emery P, et al. Among authors: sebba a. Ann Rheum Dis. 2013 Dec;72(12):1897-904. doi: 10.1136/annrheumdis-2013-203485. Epub 2013 Aug 5. Ann Rheum Dis. 2013. PMID: 23918035 Free PMC article. Review.

9

Optimizing administration of bisphosphonates in women with postmenopausal osteoporosis.

Rackoff PJ, Sebba A. Rackoff PJ, et al. Among authors: sebba a. Treat Endocrinol. 2005;4(4):245-51. doi: 10.2165/00024677-200504040-00005. Treat Endocrinol. 2005. PMID: 16053341 Review.

10

Efficacy and safety of etoricoxib in the treatment of osteoarthritis.

Sebba A. Sebba A. Expert Rev Clin Pharmacol. 2008 May;1(3):345-55. doi: 10.1586/17512433.1.3.345. Expert Rev Clin Pharmacol. 2008. PMID: 24422690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results